Shallaki (Boswellia)
Natural health product licensed in Canada
- Other names
- Boswellia, Boswellia Serrata, Shallaki
- Licence holder
- Ayur365 Inc.
- NPN or DIN-HM
- 80081157
- Status
- Active licence
- Licence date
- 9 November 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Boswellia serrata - Oléorésine (écorce de tronc) Extraction ratio : 5:1 Dry plant equivalent : 2,500 milligramme Potency : 40 % Boswellic acids | 500 milligramme | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin Extraction ratio : 5:1 Dry plant equivalent : 2,500 milligramme Potency : 40 % Boswellic acids | 500 milligramme | Not calculated |
Non-medicinal ingredients
Carbohydrate gum, Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain and swelling associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80081157
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.